prulifloxacin has been researched along with Gram-Negative Bacterial Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giannarini, G; Selli, C; Tascini, C | 1 |
Esposito, S; Ianniello, F; Leone, S; Noviello, S | 1 |
1 review(s) available for prulifloxacin and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
Topics: Adult; Aged; Clinical Trials, Phase III as Topic; Dioxolanes; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Piperazines; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
1 other study(ies) available for prulifloxacin and Gram-Negative Bacterial Infections
Article | Year |
---|---|
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections | 2006 |